TSS:Rfhg 124043.1

Basic information about the TSS

---

TSS ID: rfhg_124043.1 Species: human Chr: chr10		Start: 26861080 End: 26861084 Strand: -
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2327049,EH38E1456818)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Transcript_name: ENST00000536334.5 ENST00000490841.6 ENST00000376137.8 Distance: -3 GeneID: 10006 HGNC/MGI_ID: HGNC:11320 UniProt_ID: B6VEX3 B6VEX4 Q8IZP0

Gene_name: ABI1 Gene_symbol: ABI1 Gene_synonyms: ABI-1 E3B1 Gene_source: HGNC:11320

TATA-Box annotation

---

Distance to TSS:	5
Nearest PromoterID:	NM_001348032
Entrez ID:	10006
Nearest Unigene:	Hs.508148
Nearest Refseq:	NM_005470
Nearest Ensembl:	ENSG00000136754
Gene Name:	ABI1
Gene Alias:	ABI-1|ABLBP4|E3B1|NAP1BP|SSH3BP|SSH3BP1
Gene Description:	abl interactor 1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ABI1 p2@ABI1 p3@ABI1 p4@ABI1
Sample		p1@ABI1	p2@ABI1	p3@ABI1	p4@ABI1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	8.18	12.08	7.21	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	7.49	14.97	3.44	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8.10	15.24	5.59	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7.07	12.06	5.82	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.27	13.72	3.82	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.98	10.27	6.40	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	9.15	14.82	4.79	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	8.72	10.90	4.60	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	6.84	8.12	5.56	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	8.69	23.19	6.96	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.08	16.17	4.45	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.57	16.67	3.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.76	13.06	3.71	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	16.84	14.58	5.11	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	18.44	13.83	3.95	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.07	12.07	2.01	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.98	11.36	4.37	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.76	9.70	3.37	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.73	11.20	3.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	17.00	10.08	5.42	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	16.04	14.03	3.74	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	19.85	13.98	3.97	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.80	13.05	4.27	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	12.13	12.38	3.64	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	15.22	13.93	4.64	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	16.46	10.44	4.43	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.74	15.38	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	27.82	18.15	8.25	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	15.83	13.08	4.52	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	23.71	17.55	8.69	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	22.61	11.72	6.91	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	19.93	14.26	6.06	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.47	8.44	4.43	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	36.45	19.30	9.57	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	24.87	14.59	7.48	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	22.61	13.99	5.17	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	35.56	19.21	10.42	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	27.81	16.72	6.85	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	40.25	29.44	8.37	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	35.29	22.81	8.64	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	34.82	16.70	10.59	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	40.11	21.37	11.27	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	36.27	22.99	12.65	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	36.71	19.76	10.31	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	42.16	33.13	17.87	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	38.62	26.99	13.03	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	38.86	16.07	8.16	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	39.94	28.31	9.54	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	37.10	17.23	12.45	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	41.25	19.82	15.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	43.86	21.52	12.50	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	45.81	15.57	9.12	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	223.87	391.78	153.91	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	35.13	15.97	7.10	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	26.18	14.91	4.97	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	168.63	105.71	34.40	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	61.08	30.77	12.86	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	20.09	10.37	5.83	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.31	8.03	3.85	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	65.70	34.89	15.72	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	8.46	4.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	21.31	14.58	3.93	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	136.94	51.75	34.23	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	51.98	25.14	9.51	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.87	7.15	4.22	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.10	5.32	4.97	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	193.97	161.64	64.66	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	142.15	165.85	71.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.55	5.36	1.95	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	23.31	15.37	5.45	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	17.36	10.79	2.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	27.82	16.23	6.62	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	14.54	8.35	2.47	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	19.57	7.64	3.06	1.22
Adipocyte - breast, donor1	11376-118A8	23.60	10.29	2.53	0.16
Adipocyte - breast, donor2	11327-117E4	17.97	6.90	3.05	1.28
Adipocyte - omental, donor1	11473-119C6	25.95	6.23	2.29	0.25
Adipocyte - omental, donor2	11474-119C7	15.70	9.72	2.99	0.00
Adipocyte - omental, donor3	11475-119C8	13.73	6.70	2.34	0.67
Adipocyte - perirenal, donor1	11476-119C9	14.04	7.02	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.06	7.68	2.71	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	12.16	4.52	1.91	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	23.27	11.15	7.04	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	19.30	9.52	5.15	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	25.09	12.54	5.02	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	24.10	14.11	5.88	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	20.43	9.33	5.39	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	25.82	10.01	8.71	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	18.66	12.80	4.80	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	15.02	9.46	6.12	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	9.15	7.90	3.33	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	22.86	11.30	4.02	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	18.33	6.54	1.64	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	11.57	5.48	3.96	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	17.68	4.64	2.43	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	1.79	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	23.93	15.65	3.24	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	16.73	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	17.05	15.41	3.08	0.41
Anulus Pulposus Cell, donor1	11248-116E6	21.63	20.71	3.55	0.11
Anulus Pulposus Cell, donor2	11463-119B5	13.96	11.51	2.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	19.77	18.42	5.84	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.44	17.80	4.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	6.42	2.14	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.92	15.84	6.28	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	22.76	16.44	7.59	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.24	5.28	0.00	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.59	13.00	4.55	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	15.53	15.05	2.91	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.07	10.10	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.96	17.33	6.03	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	19.59	7.98	2.90	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	15.05	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.75	12.68	2.80	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	5.46	5.46	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.06	7.99	0.75	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.72	13.93	3.75	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.06	13.98	4.72	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	14.70	10.42	3.47	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	10.73	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	16.25	11.11	4.81	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	12.01	3.60	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	14.16	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	23.33	16.12	3.95	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.62	12.14	5.83	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.73	14.04	4.93	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	20.59	10.90	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.82	14.25	4.56	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	19.88	13.25	4.28	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.36	7.74	2.58	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	16.42	12.20	3.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	21.54	13.83	5.14	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.85	7.13	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.79	8.77	4.09	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.75	12.34	4.82	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	14.26	7.13	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	20.34	17.80	6.61	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	24.20	12.48	6.88	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	14.61	10.80	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.24	15.54	5.61	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	17.15	11.64	3.39	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.73	4.93	2.03	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	14.17	4.72	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.27	13.73	4.24	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	2.32	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	12.68	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.23	13.29	3.65	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	15.64	7.82	3.01	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.04	11.66	2.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	23.22	10.11	3.22	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.30	12.20	3.31	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	26.01	13.42	4.75	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	16.22	11.63	1.22	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	24.86	21.99	3.82	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.28	15.74	3.99	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	6.10	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	24.37	12.74	3.88	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.80	10.59	5.30	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	15.99	9.81	1.45	0.00
Astrocyte - cerebellum, donor1	11500-119F6	23.21	8.23	2.58	0.12
Astrocyte - cerebellum, donor2	11580-120F5	15.06	4.28	2.40	0.17
Astrocyte - cerebellum, donor3	11661-122F5	7.97	4.40	2.10	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	44.27	18.82	10.11	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	31.55	15.04	7.60	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	26.40	13.72	11.63	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	63.42	24.66	15.83	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	60.14	25.43	16.66	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	62.70	23.44	12.40	1.02
Basophils, donor1	12241-129G9	36.35	31.65	9.94	0.00
Basophils, donor2	12242-129H1	67.11	87.31	14.07	1.80
Basophils, donor3	12243-129H2	30.87	39.10	11.32	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	15.95	9.49	1.94	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.20	1.37	2.74	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	14.35	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	13.81	11.93	4.39	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	11.23	5.61	3.74	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	17.96	7.37	5.99	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	20.87	16.73	8.28	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	76.57	96.36	18.96	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	58.23	54.97	15.37	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	35.50	40.29	6.08	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	113.76	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	49.59	56.92	11.27	0.56
CD14+ Monocytes, donor2	11305-117B9	60.69	61.43	19.30	0.93
CD14+ Monocytes, donor3	11381-118B4	44.13	53.57	15.15	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	90.01	59.44	11.04	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	97.04	59.89	19.33	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	89.42	63.45	24.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	55.22	57.68	16.33	3.76
CD14+ monocytes - mock treated, donor2	11873-125C1	54.01	47.37	14.48	1.81
CD14+ monocytes - mock treated, donor3	11883-125D2	59.46	57.56	17.53	2.37
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	46.37	41.18	14.56	1.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	49.41	48.03	18.22	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	60.25	54.79	19.83	1.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	35.83	37.40	12.53	1.96
CD14+ monocytes - treated with BCG, donor2	11870-125B7	37.92	33.30	13.89	2.67
CD14+ monocytes - treated with BCG, donor3	11880-125C8	52.23	57.45	13.71	1.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	67.43	61.58	25.99	1.87
CD14+ monocytes - treated with Candida, donor2	11878-125C6	67.59	66.53	26.40	2.64
CD14+ monocytes - treated with Candida, donor3	11888-125D7	64.34	57.69	26.62	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	42.99	47.15	13.09	2.83
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	50.29	51.48	11.37	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	58.92	52.26	13.74	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	64.97	62.92	23.79	2.29
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	71.03	67.18	19.45	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	60.23	61.98	22.26	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	60.52	46.54	10.49	1.88
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	57.75	60.89	18.32	1.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	66.91	58.91	18.52	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	73.12	53.28	29.03	2.39
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	71.86	71.16	39.45	3.17
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	90.38	65.81	36.85	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	32.78	36.62	15.00	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	37.91	37.17	14.87	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	52.38	58.20	18.32	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	55.69	52.82	22.52	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	70.70	68.15	18.78	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	73.31	68.44	23.66	3.48
CD14+CD16+ Monocytes, donor1	11789-124B7	47.52	42.72	5.67	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	47.58	38.81	5.54	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	39.64	33.58	6.28	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	56.84	44.38	6.85	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	48.90	42.61	5.59	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	82.28	74.92	14.27	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	34.70	28.32	5.36	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	49.62	39.96	8.56	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	51.16	48.00	9.90	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	60.97	56.90	14.23	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	88.14	87.46	18.98	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	79.74	65.24	18.64	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	87.95	99.68	13.33	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	95.42	84.70	19.83	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	91.25	78.62	10.53	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	79.22	64.32	16.47	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	65.91	58.00	14.50	0.00
CD19+ B Cells, donor1	11544-120B5	67.40	85.48	17.26	2.47
CD19+ B Cells, donor2	11624-122B4	74.72	95.76	19.59	1.45
CD19+ B Cells, donor3	11705-123B4	62.09	84.31	12.62	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	56.16	14.95	13.74	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	36.35	8.39	10.79	0.00
CD34+ Progenitors, donor1	11545-120B6	25.10	42.17	6.02	0.00
CD34+ Progenitors, donor2	11625-122B5	54.50	78.09	14.61	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	42.46	34.57	6.01	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	43.52	38.33	7.44	0.23
CD4+ T Cells, donor1	11225-116C1	102.12	123.90	15.00	1.07
CD4+ T Cells, donor2	11306-117C1	80.83	96.75	24.49	5.51
CD4+ T Cells, donor3	11382-118B5	75.94	103.70	12.50	2.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	80.14	77.85	5.62	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	69.18	60.42	7.86	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	64.68	58.93	4.31	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	64.48	78.23	8.53	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	74.45	66.72	11.94	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	72.52	13.18	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	77.60	92.63	7.51	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	67.95	66.09	10.85	2.20
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	68.35	61.10	8.06	2.58
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	76.66	108.04	6.72	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	66.73	111.80	10.83	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	125.39	145.19	16.28	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	68.73	63.67	4.64	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	48.41	35.11	6.86	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	52.79	31.41	4.34	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	72.61	74.51	10.06	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	82.00	100.22	9.11	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	77.11	84.28	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	72.32	77.32	7.79	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	63.25	60.44	7.80	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	65.78	67.46	8.62	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	65.73	77.36	4.55	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	57.62	85.78	6.50	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	99.37	145.56	19.18	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	85.61	83.14	10.89	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	90.47	59.08	4.62	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	89.33	54.44	15.35	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	113.26	88.62	17.17	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	131.04	112.63	20.12	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	95.48	72.38	12.32	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	86.31	73.77	12.18	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	83.10	80.33	12.46	0.00
CD8+ T Cells, donor1	11226-116C2	104.44	106.40	12.77	0.65
CD8+ T Cells, donor2	11307-117C2	79.97	99.11	21.40	3.75
CD8+ T Cells, donor3	11383-118B6	69.43	109.58	19.69	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.89	8.49	1.84	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13.90	6.47	1.44	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	18.60	6.29	1.37	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	28.52	12.01	3.90	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	16.32	9.36	1.68	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	18.87	11.14	2.73	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.34	11.73	3.04	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	30.01	8.69	2.11	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	21.11	7.27	2.35	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	27.17	14.19	1.81	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.88	10.46	3.20	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	26.38	10.92	4.80	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	32.83	20.14	5.69	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	37.80	21.41	7.74	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	44.75	15.66	7.46	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	21.61	12.61	4.32	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	22.73	7.77	2.30	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.33	9.90	1.65	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	21.55	9.82	2.54	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	22.76	9.84	3.38	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	30.46	8.01	3.53	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.01	14.53	3.44	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	25.62	15.37	5.12	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	25.72	12.10	3.78	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	65.84	18.47	9.64	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	66.45	19.58	10.49	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	66.12	23.04	19.03	1.00
Cardiac Myocyte, donor1	11525-119I4	18.28	10.97	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	13.83	13.34	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	16.21	8.42	2.74	0.00
Chondrocyte - de diff, donor1	11261-116G1	35.36	11.79	4.85	0.00
Chondrocyte - de diff, donor2	11338-117F6	14.22	12.44	2.49	0.00
Chondrocyte - de diff, donor3	11410-118E6	19.00	13.88	3.41	0.11
Chondrocyte - re diff, donor2	11339-117F7	94.00	53.72	13.43	1.79
Chondrocyte - re diff, donor3	11411-118E7	35.18	17.39	6.87	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	28.92	12.39	5.74	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	16.67	8.98	4.06	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	19.47	10.62	4.25	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	38.24	21.82	9.35	0.37
Corneal Epithelial Cells, donor1	11526-119I5	14.05	7.69	2.20	0.00
Corneal Epithelial Cells, donor2	11606-120I4	19.34	7.96	7.96	0.00
Corneal Epithelial Cells, donor3	11687-122I4	21.22	8.18	6.39	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	38.80	41.44	3.63	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	42.26	40.06	2.52	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	27.61	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	39.31	38.12	4.54	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	55.00	66.96	16.06	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	56.15	79.00	9.79	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	72.11	68.72	23.71	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	24.01	13.51	4.34	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	11.15	13.50	1.76	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	22.06	12.16	2.83	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	23.20	14.55	3.15	0.79
Endothelial Cells - Artery, donor1	11264-116G4	12.22	7.85	1.16	0.29
Endothelial Cells - Artery, donor2	11341-117F9	16.70	9.88	3.53	0.24
Endothelial Cells - Artery, donor3	11413-118E9	19.28	7.36	5.96	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	29.92	18.40	2.88	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	33.17	18.86	6.39	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	49.33	25.65	4.51	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	19.91	16.64	3.27	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	15.10	13.54	3.64	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	15.74	12.34	1.84	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	39.61	20.81	5.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	15.20	4.19	3.14	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	36.65	27.09	3.60	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	23.90	15.64	4.56	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	31.75	13.07	7.33	0.12
Endothelial Cells - Vein, donor1	11267-116G7	10.24	5.69	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.76	5.59	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	15.39	8.48	3.77	0.47
Eosinophils, donor1	12244-129H3	121.98	91.48	0.00	0.00
Eosinophils, donor2	12245-129H4	140.27	82.51	39.61	1.65
Eosinophils, donor3	12246-129H5	92.74	46.37	46.37	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.44	6.60	1.71	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	6.24	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	27.09	21.35	7.39	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.88	5.36	1.42	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.60	7.37	1.95	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	24.86	14.07	3.52	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	45.99	19.38	7.64	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.04	9.07	2.95	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	38.47	18.44	5.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	30.23	9.97	4.65	0.00
Fibroblast - Cardiac, donor1	11268-116G8	19.51	10.89	4.08	0.45
Fibroblast - Cardiac, donor2	11345-117G4	6.06	7.58	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	9.94	8.99	2.21	0.00
Fibroblast - Cardiac, donor4	11452-119A3	27.89	16.97	2.42	0.30
Fibroblast - Cardiac, donor5	11456-119A7	22.59	15.99	5.46	0.38
Fibroblast - Cardiac, donor6	11460-119B2	25.32	14.55	4.70	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.59	13.40	2.68	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	13.81	9.92	2.59	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	17.58	4.39	5.86	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	17.53	6.92	3.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	25.44	22.22	3.39	0.34
Fibroblast - Dermal, donor1	11269-116G9	16.43	7.28	2.58	0.23
Fibroblast - Dermal, donor2	11346-117G5	23.11	7.55	2.83	0.00
Fibroblast - Dermal, donor3	11418-118F5	20.67	10.28	3.14	0.24
Fibroblast - Dermal, donor4	11450-119A1	20.35	9.95	5.43	0.00
Fibroblast - Dermal, donor5	11454-119A5	19.54	7.15	4.19	0.52
Fibroblast - Dermal, donor6	11458-119A9	24.69	9.10	6.01	0.32
Fibroblast - Gingival, donor1	11237-116D4	27.49	17.28	4.79	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	37.73	20.17	5.24	1.05
Fibroblast - Gingival, donor2	11318-117D4	20.82	11.99	5.14	0.66
Fibroblast - Gingival, donor3	11394-118C8	26.11	18.56	6.96	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	18.70	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.98	7.40	2.29	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	29.15	10.60	4.68	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	33.67	13.66	5.14	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.76	10.23	3.88	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	27.49	13.02	5.12	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	37.50	14.59	4.91	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	34.99	11.30	6.36	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	27.29	13.21	5.14	0.44
Fibroblast - Lung, donor1	11270-116H1	13.59	4.08	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	19.40	32.83	10.45	0.00
Fibroblast - Lung, donor3	11419-118F6	11.18	6.33	4.01	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	31.65	13.33	6.66	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	4.20	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.76	1.12	1.12	0.28
Fibroblast - Mammary, donor1	11540-120B1	35.73	12.59	6.09	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	3.99	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	17.87	23.83	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	25.02	10.47	3.88	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	22.75	10.47	7.43	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	44.67	13.77	9.49	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	25.19	11.83	4.20	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	16.47	12.42	3.78	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.22	8.35	5.10	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	18.57	11.05	3.43	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	23.16	8.94	4.06	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.04	5.35	3.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.61	10.28	3.16	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	45.84	22.03	11.51	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	27.35	11.72	1.95	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	33.31	11.04	2.56	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	31.59	17.45	6.32	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	46.64	23.43	8.53	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	43.53	23.03	6.83	0.25
Fibroblast - skin normal, donor1	11553-120C5	28.71	15.26	4.27	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	60.35	29.47	8.62	0.60
Fibroblast - skin normal, donor2	11561-120D4	55.96	26.32	7.64	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	59.54	28.11	10.28	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	30.49	16.82	3.07	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	48.89	24.96	5.98	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	32.19	21.35	6.90	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	45.06	18.96	7.99	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	26.31	13.66	3.04	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	27.91	18.66	5.49	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	243.76	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	69.72	78.44	14.82	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	40.74	18.03	7.97	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	44.24	24.72	13.53	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	44.71	17.37	13.03	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	8.42	3.06	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	13.40	14.68	1.91	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	32.52	11.98	14.26	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	21.51	6.89	7.17	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	19.86	7.76	7.99	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	16.64	9.11	7.13	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	23.26	7.40	6.61	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	21.20	5.87	4.89	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	21.67	11.94	10.61	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	16.53	13.43	5.09	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	14.53	13.30	5.79	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	15.85	9.13	4.30	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	21.31	14.12	9.91	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	24.09	17.30	11.35	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	24.40	13.82	9.35	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	17.80	11.41	4.11	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	20.18	10.84	8.35	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	19.89	11.37	12.24	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	14.77	9.75	5.91	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	14.94	11.13	6.68	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	15.19	10.95	5.59	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	13.91	9.48	3.43	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	15.27	13.74	4.75	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	28.91	12.77	5.14	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.91	20.60	4.16	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.37	21.86	3.76	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	18.70	13.39	7.08	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.13	12.56	4.08	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	23.07	15.72	3.27	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	18.77	17.12	5.98	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	18.56	12.11	6.80	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	15.34	11.84	4.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	17.41	14.11	6.39	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	19.19	15.13	7.50	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	17.34	12.16	3.89	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	22.77	16.36	8.34	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	20.28	14.78	5.21	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.87	12.18	3.48	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	24.33	21.29	6.39	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	21.01	18.40	6.27	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	16.69	13.61	5.05	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.92	16.55	5.05	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.94	20.18	5.74	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	16.85	14.97	4.01	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	15.76	16.37	3.98	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	18.91	15.93	5.44	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	15.45	17.35	7.59	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	23.60	22.49	6.64	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	17.98	22.59	7.46	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	35.70	30.74	15.87	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	16.09	16.23	4.62	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.32	11.70	3.83	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	55.92	50.83	9.66	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	26.67	20.50	8.76	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	13.87	15.72	6.93	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	23.12	19.44	8.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.07	8.14	2.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	10.74	7.06	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	16.60	11.53	4.61	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	12.37	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	27.46	14.70	5.42	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	8.02	6.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	13.91	10.43	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	20.51	10.74	2.93	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	19.77	17.30	5.35	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	3.33	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	23.21	10.07	6.99	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	22.55	9.15	3.92	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	20.13	6.71	5.87	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	23.22	14.95	5.41	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.34	9.85	7.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	16.71	12.53	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	21.19	7.45	8.59	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	9.77	4.14	2.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	6.78	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	21.54	16.15	7.87	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	19.79	9.67	5.29	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	16.53	9.61	4.23	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	18.58	11.08	6.85	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	14.71	9.36	2.68	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	14.64	11.94	6.55	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	22.59	16.77	7.53	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	4.97	9.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	18.87	12.74	7.08	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.90	9.66	4.83	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	11.19	7.63	6.10	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	19.14	10.77	5.18	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	17.76	11.84	6.41	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	18.89	1.18	16.53	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.09	6.42	5.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	9.66	5.27	4.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	13.56	10.17	6.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.36	14.92	4.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	17.95	8.73	5.34	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	5.71	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.81	7.07	2.49	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	16.87	5.62	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	17.76	10.15	2.85	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.03	7.52	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	16.94	6.50	3.13	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	18.23	6.25	2.36	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.84	3.87	2.50	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.85	6.45	3.06	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	15.69	6.23	3.22	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	17.01	4.52	2.15	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.68	6.48	3.86	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.24	6.35	3.77	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	9.93	7.37	4.49	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	20.71	12.87	4.48	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	10.39	5.19	2.60	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	15.86	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	13.76	7.41	2.12	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	12.35	2.91	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	13.64	7.17	3.50	0.00
Hepatocyte, donor1	11523-119I2	39.95	10.90	2.42	0.00
Hepatocyte, donor2	11603-120I1	18.31	15.08	3.23	0.00
Hepatocyte, donor3	11684-122I1	35.59	14.72	9.82	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	33.29	46.99	8.48	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	30.76	19.93	13.98	1.57
Iris Pigment Epithelial Cells, donor1	11530-119I9	18.52	11.53	5.21	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	6.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	5.01	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	4.87	3.25	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	5.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	6.65	1.11	3.33	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	10.48	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.67	5.04	2.52	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	6.19	4.64	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	3.88	3.23	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	5.70	1.63	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.20	1.26	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	7.23	2.41	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	1.85	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.61	1.42	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	3.63	0.91	3.63	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	4.30	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	2.54	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.65	3.19	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	6.43	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	3.32	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.03	3.09	1.54	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	1.76	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	8.34	3.48	2.09	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	2.21	6.64	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	8.72	3.49	1.74	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	3.20	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	2.85	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	2.76	1.84	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	2.11	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	27.17	15.50	4.73	0.00
Keratinocyte - epidermal, donor2	11349-117G8	6.44	1.76	2.93	0.59
Keratinocyte - epidermal, donor3	11421-118F8	24.71	18.84	8.71	0.47
Keratinocyte - oral, donor1	11251-116E9	51.65	34.06	10.33	0.23
Keratocytes, donor1	11527-119I6	7.91	3.44	1.72	0.00
Keratocytes, donor2	11607-120I5	14.06	4.69	2.34	0.00
Keratocytes, donor3	11688-122I5	7.11	6.13	1.98	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	13.19	26.37	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	6.47	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	24.10	11.53	5.31	0.12
Lens Epithelial Cells, donor3	11690-122I7	22.70	11.40	3.83	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	26.68	17.79	2.96	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	18.98	10.88	1.67	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	23.30	16.06	2.68	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	18.28	7.53	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.61	8.51	1.58	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.02	10.57	1.40	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	26.27	9.03	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.35	7.58	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	15.62	11.54	1.41	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	20.17	15.43	2.37	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	20.36	15.90	3.49	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.00	6.85	0.93	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	16.72	17.07	2.44	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.31	9.54	1.67	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	13.05	8.79	1.51	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	24.02	12.63	1.85	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.29	7.48	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.16	8.05	1.65	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.67	14.48	3.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.49	5.56	1.17	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	11.70	4.98	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	20.37	12.12	1.94	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.77	14.54	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	18.62	13.62	2.12	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.59	15.03	2.07	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	23.45	14.03	3.77	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	14.89	9.77	2.86	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	13.76	2.75	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	21.64	12.79	3.01	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.72	9.22	2.01	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.35	8.24	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.22	9.92	2.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	16.60	10.16	1.24	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	27.40	16.66	2.22	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.06	9.88	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	13.47	7.56	1.51	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	26.05	12.54	1.93	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.04	15.22	3.35	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	23.09	15.68	2.94	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	20.98	12.80	2.84	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.03	7.76	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.74	5.60	1.24	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	17.19	13.61	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	17.64	12.74	3.59	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.06	4.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.49	14.97	3.22	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.96	8.20	3.07	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	15.51	10.14	2.09	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	10.74	2.30	6.90	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	7.42	10.39	3.71	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	14.81	8.46	4.65	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	5.63	2.81	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	10.27	4.67	3.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	8.76	8.24	4.64	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	17.84	9.52	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.99	5.88	4.07	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	17.45	8.43	3.78	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	15.31	11.25	4.95	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	18.70	6.91	4.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	13.35	6.16	3.59	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	16.58	11.29	3.88	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.99	9.33	2.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.75	10.70	2.04	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	15.21	9.61	5.07	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	22.11	10.20	6.99	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	19.63	4.29	4.91	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	24.46	13.05	6.52	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.87	12.91	6.04	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.90	11.77	4.48	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	11.33	9.27	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.45	8.71	4.06	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.04	7.47	3.59	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	15.49	9.96	5.53	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	14.85	10.96	6.36	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.01	7.74	4.79	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	16.12	2.30	5.76	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	16.12	9.59	4.61	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	15.29	9.06	5.66	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	15.59	8.20	6.56	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.30	7.23	6.78	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	13.64	5.03	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.18	6.72	8.96	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	23.41	3.72	6.32	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	17.23	6.89	2.58	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	16.27	6.85	5.14	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	18.32	7.00	5.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	20.51	3.62	2.41	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	15.64	3.55	2.84	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	13.06	8.59	5.84	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	24.69	8.59	2.15	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	19.53	4.71	6.06	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	19.26	7.78	3.70	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	6.98	13.96	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	2.12	5.29	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	19.21	7.60	2.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	14.54	8.00	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.93	8.43	6.90	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	17.26	11.84	8.39	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	0.94	0.94	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	13.58	6.03	4.02	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.07	8.56	6.31	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	8.61	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	21.38	8.46	6.23	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.81	6.65	8.21	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.19	4.62	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	15.05	9.86	3.63	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	18.38	9.63	12.69	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	18.45	8.95	4.47	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	13.69	7.51	5.74	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.51	8.87	4.63	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.17	8.10	3.04	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	16.34	6.73	4.33	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.08	10.34	6.76	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	15.80	9.72	3.04	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.22	4.15	3.46	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	19.76	8.36	7.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.07	5.16	5.16	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	11.49	5.44	4.23	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	18.38	6.65	6.34	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	15.46	7.46	5.86	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	8.05	4.02	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	17.48	7.20	6.69	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	23.34	7.07	3.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	15.89	6.24	1.70	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	18.72	12.48	4.99	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	6.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	21.71	5.43	5.01	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14.87	5.11	4.18	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	17.40	3.35	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	16.04	6.42	2.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	18.99	10.91	3.23	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	6.42	2.75	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	21.34	2.67	3.56	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.24	5.70	5.13	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.87	5.37	4.60	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.30	6.02	2.74	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	11.14	2.23	4.01	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	13.78	4.68	3.90	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	7.96	4.64	5.30	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	6.24	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	67.46	52.19	7.07	0.91
Macrophage - monocyte derived, donor2	11313-117C8	57.07	25.14	4.40	0.00
Macrophage - monocyte derived, donor3	11389-118C3	56.76	36.05	9.57	1.70
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.55	19.12	4.25	0.00
Mallassez-derived cells, donor2	11929-125I3	54.51	37.39	13.79	0.48
Mallassez-derived cells, donor3	11930-125I4	50.87	30.99	9.87	0.14
Mammary Epithelial Cell, donor1	11273-116H4	50.32	29.89	8.77	0.50
Mammary Epithelial Cell, donor2	11350-117G9	39.38	29.82	4.63	0.58
Mammary Epithelial Cell, donor3	11422-118F9	10.97	6.98	3.24	0.00
Mast cell - stimulated, donor1	11487-119E2	121.35	145.08	6.10	0.00
Mast cell, donor1	11563-120D6	53.75	42.28	4.00	0.22
Mast cell, donor2	11565-120D8	76.37	54.68	10.40	0.30
Mast cell, donor3	11566-120D9	73.17	46.83	12.83	0.23
Mast cell, donor4	11567-120E1	65.42	40.24	8.69	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	70.97	43.03	5.21	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	46.11	28.60	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	48.53	27.53	2.64	0.23
Mast cell, expanded, donor8	11941-126A6	46.53	28.45	3.18	0.84
Melanocyte - dark, donor1	11502-119F8	30.35	21.19	3.68	0.00
Melanocyte - dark, donor2	11582-120F7	12.81	14.88	2.77	0.00
Melanocyte - dark, donor3	11663-122F7	36.29	18.47	6.30	0.14
Melanocyte - light, donor1	11274-116H5	14.57	6.11	2.59	0.71
Melanocyte - light, donor2	11351-117H1	10.92	6.14	2.05	0.00
Melanocyte - light, donor3	11423-118G1	3.47	3.47	2.60	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	22.07	12.60	5.31	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	17.48	14.52	4.30	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	32.95	21.43	10.18	0.80
Meningeal Cells, donor1	11493-119E8	35.98	14.39	5.95	0.00
Meningeal Cells, donor2	11573-120E7	27.73	9.68	3.52	0.00
Meningeal Cells, donor3	11654-122E7	32.03	11.41	3.34	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	24.52	9.98	4.85	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	23.75	19.93	2.82	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	14.35	2.87	5.02	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	24.35	12.92	3.39	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	15.58	10.56	3.52	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	13.19	5.27	2.64	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	5.11	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.25	3.48	1.64	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.58	13.02	2.63	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.09	2.60	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	17.76	9.08	2.24	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.61	2.97	1.19	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	4.67	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	13.45	3.20	1.92	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	29.06	11.70	4.25	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.95	6.57	2.81	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.16	3.63	4.35	0.00
Mesothelial Cells, donor1	11247-116E5	23.07	6.63	3.71	0.00
Mesothelial Cells, donor2	12156-128G5	14.01	6.51	3.00	0.50
Mesothelial Cells, donor3	11402-118D7	20.38	7.15	3.97	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	33.76	17.55	9.45	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	68.96	49.99	12.81	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	67.14	31.80	5.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	37.19	38.74	8.68	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	48.12	27.59	4.98	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	4.63	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	48.30	42.54	10.26	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	46.08	25.60	7.91	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	51.41	36.78	8.54	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	47.52	19.80	7.13	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	43.36	29.20	8.85	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	52.43	26.98	7.22	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	27.63	9.21	5.26	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	53.27	40.75	8.91	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	35.91	13.81	6.45	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	52.76	39.94	12.82	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	57.01	5.03	8.38	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	67.74	59.46	18.32	1.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	50.39	29.71	8.32	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	35.38	16.03	17.69	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	96.70	83.58	19.11	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	67.10	34.92	8.20	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	84.18	66.24	21.40	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	80.45	79.38	17.16	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	75.13	37.12	13.12	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	30.96	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	104.91	91.55	25.41	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	69.96	28.90	12.67	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	41.42	23.20	36.45	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	122.03	104.37	36.42	2.17
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	99.69	52.35	11.47	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	74.14	17.45	21.81	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	93.71	69.20	27.87	2.88
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	103.66	42.82	16.41	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	83.64	34.28	54.85	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	121.64	90.10	33.54	3.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	65.23	46.89	40.77	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	123.06	95.47	32.84	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	86.08	28.69	20.97	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	87.73	23.69	49.31	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	134.62	102.14	41.90	3.22
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	56.37	27.14	20.88	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	108.28	55.25	46.41	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	90.60	66.32	31.11	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	64.77	31.51	21.01	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	72.44	28.76	36.22	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	82.48	68.17	33.11	3.37
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	66.50	36.99	26.18	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	68.18	20.98	31.47	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	79.34	53.70	23.53	1.81
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	91.41	55.10	24.21	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	28.88	43.31	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	53.57	41.56	34.17	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	79.11	42.68	33.58	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	72.82	44.77	25.84	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	79.30	55.46	26.69	3.11
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	85.37	44.61	27.88	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	58.44	14.61	28.58	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	61.92	50.18	24.82	1.33
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	88.30	39.21	27.24	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	55.65	32.06	20.34	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	71.03	40.77	27.71	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	99.95	56.17	34.72	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	72.81	33.37	25.03	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	84.38	59.38	29.55	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	98.08	54.57	31.95	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	61.26	18.90	25.42	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	61.16	48.22	30.28	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	77.27	39.79	21.05	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	73.36	41.21	26.79	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	48.24	44.67	18.76	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	22.60	11.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	32.08	24.95	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	65.71	60.46	18.40	2.96
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	36.82	29.45	4.21	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	41.32	35.78	3.16	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	54.02	40.98	9.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	56.33	50.70	9.39	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	39.69	31.43	6.92	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	60.96	48.97	10.63	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	36.10	26.52	3.68	3.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	57.90	44.70	11.73	2.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	60.67	42.00	9.33	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	75.89	80.17	15.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	23.18	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	26.26	29.29	20.20	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	61.98	35.84	8.43	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	72.18	89.89	24.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	75.66	89.01	15.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	115.00	136.86	29.15	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	69.48	42.29	15.10	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	79.94	28.55	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	97.87	71.77	13.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	90.30	95.05	23.76	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	50.20	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	24.78	14.00	2.37	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.72	16.20	5.23	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	15.35	4.00	2.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.76	1.67	1.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	59.89	21.87	13.31	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	46.28	11.17	4.79	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	4.08	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	75.34	60.64	23.89	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.44	3.77	0.84	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.27	7.90	3.02	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.00	3.78	1.62	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	20.39	9.67	3.78	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	178.16	100.21	33.40	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.93	5.96	0.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.68	15.97	3.25	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.16	5.21	1.59	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.57	6.04	0.98	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.87	13.67	4.19	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.02	1.06	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	11.41	4.20	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	53.16	31.50	14.11	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.62	3.74	1.79	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.05	16.05	4.59	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	2.81	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.65	5.98	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	7.07	5.46	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	63.46	35.18	13.80	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	212.39	83.44	60.68	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	17.15	10.47	5.35	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.47	5.93	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	15.67	13.77	4.75	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.44	6.01	3.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	225.69	207.64	45.14	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.66	8.00	2.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.66	4.06	1.35	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.92	2.38	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	7.43	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	16.65	11.35	1.89	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	6.84	3.26	2.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	8.72	3.92	2.61	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	11.76	7.24	1.81	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	4.41	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.96	1.99	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.94	2.98	2.48	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.13	3.83	1.53	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	16.94	7.26	3.63	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	18.79	9.73	3.76	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	2.03	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	97.08	51.10	30.66	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	6.10	4.88	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.13	4.41	1.89	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.90	3.93	2.12	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	3.96	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	52.15	32.88	9.07	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	101.16	65.75	20.23	0.00
Myoblast, donor1	11241-116D8	21.37	10.19	4.47	0.62
Myoblast, donor2	11322-117D8	23.01	10.55	4.22	0.96
Myoblast, donor3	11398-118D3	23.54	11.44	3.53	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	31.23	24.37	11.24	0.29
Natural Killer Cells, donor1	11230-116C6	102.71	94.72	8.92	1.54
Natural Killer Cells, donor2	11311-117C6	73.88	91.67	19.00	0.90
Natural Killer Cells, donor3	11387-118C1	67.18	89.45	17.85	1.29
Neural stem cells, donor1	11275-116H6	69.32	34.12	8.35	0.36
Neural stem cells, donor2	11352-117H2	57.77	55.84	7.70	1.93
Neurons, donor1	11494-119E9	42.10	37.55	11.38	0.00
Neurons, donor2	11574-120E8	32.58	23.56	9.03	0.00
Neurons, donor3	11655-122E8	27.95	26.31	10.69	3.29
Neutrophils, donor1	11233-116C9	148.48	59.39	29.70	4.64
Neutrophils, donor2	11314-117C9	101.46	40.58	17.39	11.60
Neutrophils, donor3	11390-118C4	263.88	101.40	83.69	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	24.82	24.10	3.44	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	12.70	7.49	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	14.84	5.62	3.81	0.20
Olfactory epithelial cells, donor1	11933-125I7	15.14	13.35	3.44	0.14
Olfactory epithelial cells, donor2	11934-125I8	20.26	14.33	4.34	1.59
Olfactory epithelial cells, donor3	11935-125I9	20.20	12.60	3.97	0.57
Olfactory epithelial cells, donor4	11936-126A1	19.77	10.42	3.60	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	27.68	12.04	6.62	0.00
Osteoblast - differentiated, donor1	11276-116H7	12.34	10.42	2.77	0.21
Osteoblast - differentiated, donor2	11353-117H3	4.57	3.43	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	9.93	14.28	3.72	0.00
Osteoblast, donor1	11277-116H8	14.07	5.67	2.15	0.20
Osteoblast, donor2	11354-117H4	36.52	17.56	2.11	0.00
Osteoblast, donor3	11426-118G4	20.44	9.95	4.98	0.18
Pancreatic stromal cells, donor1	11249-116E7	34.37	15.25	5.64	0.34
Pericytes, donor1	11491-119E6	8.46	4.78	1.22	0.11
Pericytes, donor2	11571-120E5	9.96	4.98	1.58	0.23
Pericytes, donor3	11652-122E5	10.58	3.87	2.85	0.41
Perineurial Cells, donor1	11499-119F5	21.81	9.49	4.86	0.11
Perineurial Cells, donor2	11579-120F4	25.21	17.76	4.97	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	88.93	73.63	9.88	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	54.11	53.14	14.45	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	52.93	59.01	10.61	0.39
Placental Epithelial Cells, donor1	11278-116H9	13.15	5.98	3.35	0.00
Placental Epithelial Cells, donor2	11355-117H5	9.98	7.76	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	11.58	6.87	1.77	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.66	9.49	3.48	0.95
Preadipocyte - breast, donor1	11467-119B9	28.33	11.63	3.00	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	40.86	21.54	7.70	0.39
Preadipocyte - breast, donor2	11328-117E5	24.09	11.03	7.20	0.90
Preadipocyte - omental, donor1	11468-119C1	25.68	9.59	2.34	0.21
Preadipocyte - omental, donor2	11329-117E6	36.66	16.15	5.67	0.00
Preadipocyte - omental, donor3	11403-118D8	26.50	9.74	5.16	0.43
Preadipocyte - perirenal, donor1	11469-119C2	9.84	0.98	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	12.90	4.30	1.84	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	30.81	12.57	6.55	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	19.41	11.24	3.75	0.34
Preadipocyte - visceral, donor1	11280-116I2	37.45	17.79	6.71	0.19
Preadipocyte - visceral, donor2	11357-117H7	25.77	12.42	3.22	0.92
Preadipocyte - visceral, donor3	11429-118G7	23.09	10.66	4.70	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	25.04	14.48	8.60	0.45
Prostate Epithelial Cells, donor2	11331-117E8	26.00	11.24	4.60	0.95
Prostate Epithelial Cells, donor3	11404-118D9	24.13	11.94	9.98	0.67
Prostate Stromal Cells, donor1	11254-116F3	18.45	6.83	4.33	0.46
Prostate Stromal Cells, donor2	11332-117E9	26.18	8.07	5.74	0.54
Prostate Stromal Cells, donor3	11405-118E1	15.43	6.78	3.34	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.77	3.28	2.55	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	32.30	10.33	8.80	0.49
Renal Epithelial Cells, donor1	11517-119H5	8.12	0.00	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	8.54	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	31.34	12.70	4.66	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.26	4.09	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.31	6.33	2.43	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	17.09	10.66	4.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	10.12	4.18	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	4.39	6.27	2.51	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.50	1.39	0.83	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	28.18	7.52	4.03	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.92	5.06	5.48	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.41	3.66	2.51	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	13.48	8.30	4.15	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	12.51	7.67	3.41	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	2.06	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.78	6.02	1.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	45.84	21.78	9.76	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	21.44	8.93	5.36	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	61.64	37.43	3.85	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	63.23	27.84	7.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	43.56	15.08	11.57	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.54	10.72	8.34	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	36.03	12.38	5.58	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	46.89	16.87	14.76	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	25.76	8.97	8.04	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	39.99	16.41	10.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	27.93	8.76	10.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	26.78	9.98	6.20	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	22.76	7.88	4.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	23.24	12.19	9.04	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	22.75	9.77	8.16	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	30.76	11.95	7.30	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	27.53	13.96	8.22	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	26.64	10.15	6.89	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	48.86	14.09	6.95	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	33.57	11.55	11.28	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	28.81	9.83	9.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	32.65	12.99	7.07	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	29.80	12.60	9.18	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	20.74	9.81	4.48	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	28.71	12.30	8.20	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.44	10.21	10.39	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	24.28	9.20	8.46	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	23.64	10.48	6.45	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	28.07	16.98	6.13	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	26.79	9.52	6.75	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	29.23	13.10	7.95	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	23.43	9.95	7.88	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	33.40	11.50	4.42	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.57	10.03	5.85	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	32.03	12.11	8.21	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	29.63	7.83	8.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	32.58	11.18	5.98	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	29.23	12.21	9.80	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	29.22	8.64	6.72	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	33.98	9.85	8.54	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	29.83	13.63	10.40	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	30.48	10.50	8.73	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	29.59	14.13	9.60	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	27.38	18.11	11.75	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	25.95	11.67	6.43	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	40.91	16.73	10.88	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	32.77	14.22	8.66	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.59	19.91	8.04	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	32.03	19.34	8.76	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	27.90	13.71	8.08	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	74.96	27.95	9.75	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	27.99	17.64	9.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	33.15	15.37	8.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	35.51	13.80	4.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	35.05	14.08	11.68	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	44.04	16.88	8.50	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	32.44	14.51	7.68	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	22.24	17.43	8.41	0.60
Schwann Cells, donor1	11498-119F4	8.09	3.01	1.88	0.19
Schwann Cells, donor2	11578-120F3	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	13.36	8.33	2.41	0.00
Sebocyte, donor1	11220-116B5	39.44	25.75	7.12	0.00
Sebocyte, donor2	11301-117B5	30.33	19.76	9.19	0.92
Sebocyte, donor3	11378-118B1	15.46	12.57	4.74	0.62
Sertoli Cells, donor1	11255-116F4	21.54	8.28	4.97	0.00
Sertoli Cells, donor2	11333-117F1	11.30	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	12.14	9.06	2.46	0.00
Skeletal Muscle Cells, donor2	11358-117H8	4.34	2.17	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.87	6.69	3.34	0.00
Skeletal Muscle Cells, donor4	11451-119A2	18.54	5.50	2.36	0.31
Skeletal Muscle Cells, donor5	11455-119A6	16.20	8.03	2.82	0.45
Skeletal Muscle Cells, donor6	11459-119B1	19.08	6.62	4.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	28.35	19.03	3.40	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.83	9.85	3.28	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.35	9.82	3.17	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.40	9.27	2.36	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	9.41	2.90	5.07	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.90	8.12	4.40	0.28
Skin - palm, donor1	10286-104F7	64.47	75.21	18.80	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.59	11.24	3.03	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	124.32	76.06	15.54	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	18.05	8.44	2.60	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	44.07	14.60	9.17	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	35.73	19.27	14.35	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	98.53	55.61	20.51	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	24.36	10.42	10.42	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	26.23	12.34	3.70	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	29.13	13.34	7.78	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.34	4.70	3.53	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	22.54	15.03	6.19	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.39	5.91	1.58	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	15.45	5.41	3.09	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	19.01	15.01	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.30	5.72	3.46	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	18.62	8.87	4.88	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.67	13.70	8.07	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	21.49	7.81	1.95	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.90	11.52	5.02	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.81	5.27	3.84	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.02	2.60	1.79	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	11.26	10.66	3.04	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.67	11.11	1.52	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	3.81	2.86	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	21.24	5.16	3.98	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.78	6.46	2.37	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	14.17	5.98	1.99	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.99	4.95	3.40	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	7.55	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.35	7.77	3.89	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.83	2.39	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.24	15.55	3.53	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	25.86	11.78	2.82	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	24.80	12.29	6.14	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.68	4.83	2.42	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	28.88	6.89	5.03	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	30.09	9.19	4.93	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	18.16	8.64	3.38	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.02	9.89	1.52	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.80	10.25	2.56	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	3.75	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	82.70	72.36	47.81	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	9.77	6.51	1.86	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	15.15	10.10	4.04	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	12.54	5.95	4.07	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.08	2.95	1.47	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	25.16	8.00	6.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.95	7.01	2.80	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.54	9.50	2.88	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	17.34	6.37	4.84	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.60	6.21	2.26	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	27.81	11.04	6.15	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	18.77	7.12	3.69	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.14	0.95	1.90	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	16.39	11.99	4.89	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	34.91	13.04	6.19	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	19.60	6.73	5.56	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	14.38	10.30	2.72	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	21.42	8.73	3.17	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	30.87	14.88	2.23	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.61	8.98	2.87	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.65	4.26	3.69	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	27.57	12.60	1.58	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	21.08	9.40	2.79	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	9.98	7.59	3.99	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	12.12	5.02	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	13.75	9.17	0.92	0.46
Synoviocyte, donor1	11291-117A4	34.34	16.16	2.19	0.34
Synoviocyte, donor2	11368-117I9	26.82	15.42	3.69	0.84
Synoviocyte, donor3	11440-118H9	24.35	11.62	4.02	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	13.22	5.36	2.50	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.80	4.17	2.32	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	25.66	12.83	3.94	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	11.98	7.34	2.32	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	14.32	6.30	4.01	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	49.09	19.44	8.98	0.12
Urethra, donor2	10319-105A4	61.15	26.98	16.19	0.00
Urothelial Cells, donor1	11520-119H8	14.88	5.58	3.19	0.27
Urothelial Cells, donor2	11600-120H7	14.42	6.81	4.01	0.00
Urothelial Cells, donor3	11681-122H7	11.00	6.65	2.52	0.46
Urothelial cells, donor0	11216-116B1	41.01	22.29	8.92	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	181.52	64.06	22.24	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	180.13	67.19	25.73	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	67.77	35.60	21.90	3.42
Whole blood (ribopure), donor090325, donation1	12176-128I7	110.53	58.54	6.89	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	106.33	51.71	4.65	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	160.35	63.52	16.66	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	161.53	59.66	14.68	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	71.21	32.86	13.69	0.91
Wilms' tumor cell line:G-401	10809-111A8	22.58	8.88	3.95	0.74
Wilms' tumor cell line:HFWT	10597-108E3	21.12	5.28	3.52	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	18.99	11.73	3.63	0.56
achilles tendon, donor2	10292-104G4	53.73	26.86	8.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	50.99	36.46	12.24	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	55.95	38.77	13.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	77.99	64.81	26.00	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	51.97	29.39	7.35	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	40.48	21.92	7.87	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	52.87	31.93	5.08	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	33.75	28.04	6.26	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	66.54	57.28	9.69	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	56.35	71.05	4.90	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	44.27	68.73	5.82	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	26.86	18.95	3.50	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	66.31	15.60	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	53.22	40.20	7.67	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	50.74	28.22	8.54	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	30.69	22.50	3.51	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	28.82	13.48	5.58	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	37.84	27.55	3.70	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	14.43	7.98	3.99	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	41.82	19.63	8.11	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	43.07	27.60	4.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	52.23	27.92	7.46	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	23.61	15.81	3.79	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	37.36	10.01	2.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	59.46	24.16	7.43	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	56.50	19.21	9.79	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	29.66	17.88	4.80	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	89.97	22.49	13.12	0.00
adenocarcinoma cell line:IM95m	10796-110I4	42.39	16.48	13.19	0.00
adipose tissue, adult, pool1	10010-101C1	48.24	20.17	5.74	0.00
adipose, donor1	10184-103D4	58.05	15.25	28.73	0.59
adipose, donor2	10185-103D5	7.30	2.84	2.84	0.00
adipose, donor3	10186-103D6	14.16	13.07	4.90	0.27
adipose, donor4	10187-103D7	15.60	17.34	7.80	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.51	14.68	8.84	0.00
adrenal gland, adult, pool1	10081-102A9	21.83	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	51.49	19.88	8.94	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	36.44	12.51	7.15	1.43
amniotic membrane cells, donor1	12235-129G3	49.85	30.84	10.90	0.46
amniotic membrane cells, donor2	12236-129G4	29.75	17.24	7.10	0.34
amniotic membrane cells, donor3	12237-129G5	60.98	26.51	15.91	0.00
amygdala - adult, donor10196	10167-103B5	77.08	36.76	18.97	4.74
amygdala, adult, donor10252	10151-102I7	67.72	33.46	30.62	1.22
amygdala, newborn, donor10223	10360-105E9	40.02	11.94	4.84	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	31.32	35.14	7.77	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	16.11	8.16	3.75	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	40.42	26.72	6.68	0.67
aorta, adult, pool1	10052-101G7	33.34	20.40	9.81	0.59
appendix, adult	10189-103D9	72.97	44.25	10.09	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	31.30	20.29	9.97	0.69
artery, adult	10190-103E1	19.02	8.15	6.79	0.00
astrocytoma cell line:TM-31	10425-106D2	19.70	15.94	5.65	0.00
b cell line:RPMI1788	10427-106D4	53.83	29.15	11.75	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	29.41	17.20	6.38	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	22.92	13.40	6.05	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	14.56	14.90	9.04	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	19.01	24.61	8.39	2.24
bladder, adult, pool1	10011-101C2	43.35	19.34	14.99	0.11
blood, adult, pool1	10053-101G8	33.22	33.22	13.29	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.12	22.27	5.99	0.00
bone marrow, adult	10192-103E3	41.84	26.32	4.05	0.00
brain, adult, donor1	10084-102B3	25.63	15.38	15.38	0.00
brain, adult, pool1	10012-101C3	50.89	27.51	12.69	0.45
brain, fetal, pool1	10085-102B4	21.37	13.36	13.36	0.00
breast carcinoma cell line:MCF7	10482-107A5	57.15	34.03	20.81	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	33.58	17.23	8.99	0.12
breast, adult, donor1	10080-102A8	23.99	5.68	6.31	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	29.60	20.45	7.50	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	13.30	10.82	3.09	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	44.66	23.94	8.75	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	26.39	9.68	4.84	0.00
carcinoid cell line:NCI-H1770	10703-109H1	3.76	3.29	2.35	0.00
carcinoid cell line:NCI-H727	10735-110B6	17.94	11.59	4.81	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	7.29	6.34	1.90	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	16.50	18.37	2.40	0.27
caudate nucleus - adult, donor10196	10177-103C6	84.05	42.60	32.24	3.45
caudate nucleus, adult, donor10252	10164-103B2	66.26	34.97	28.45	0.67
caudate nucleus, adult, donor10258	10379-105H1	42.79	16.05	6.11	1.53
caudate nucleus, newborn, donor10223	10354-105E3	34.43	24.54	9.52	1.10
cerebellum - adult, donor10196	10173-103C2	75.75	67.01	37.87	8.74
cerebellum, adult, donor10252	10166-103B4	67.47	36.51	48.47	2.14
cerebellum, adult, pool1	10083-102B2	23.11	24.15	12.07	0.00
cerebellum, newborn, donor10223	10357-105E6	69.74	46.50	12.45	1.66
cerebral meninges, adult	10188-103D8	57.99	21.43	13.11	0.25
cerebrospinal fluid, donor2	10294-104G6	24.12	12.43	4.39	1.46
cervical cancer cell line:D98-AH2	10552-107I3	15.53	20.56	2.30	0.00
cervical cancer cell line:ME-180	10553-107I4	50.05	38.45	25.69	0.50
cervix, adult, pool1	10013-101C4	51.03	29.19	13.65	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	16.72	10.73	5.29	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	5.23	11.76	0.00
choriocarcinoma cell line:BeWo	10423-106C9	25.97	10.56	9.20	0.25
choriocarcinoma cell line:SCH	10785-110H2	33.76	20.82	14.54	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	15.65	8.78	10.44	0.00
chorionic membrane cells, donor1	12238-129G6	36.75	20.23	11.11	0.57
chorionic membrane cells, donor2	12239-129G7	26.85	13.62	10.94	0.40
chorionic membrane cells, donor3	12240-129G8	50.55	34.62	18.68	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	16.16	29.28	3.03	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	49.56	32.46	5.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	55.75	16.68	7.81	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	29.28	8.73	6.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	35.56	12.34	5.81	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	43.57	12.22	7.33	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	43.28	10.01	6.77	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	67.50	38.83	8.34	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	35.20	18.52	6.17	1.14
clear cell carcinoma cell line:TEN	10636-108I6	20.82	12.49	7.46	0.17
colon carcinoma cell line:CACO-2	10513-107D9	51.25	26.91	23.80	0.18
colon carcinoma cell line:COLO-320	10420-106C6	34.97	36.49	12.16	0.00
colon, adult, donor1	10082-102B1	27.37	7.14	9.52	1.19
colon, adult, pool1	10014-101C5	39.95	26.56	10.58	0.00
colon, fetal, donor1	10070-101I7	31.52	19.78	9.89	1.85
common myeloid progenitor CMP, donor1	12130-128D6	32.08	22.92	13.75	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	100.71	40.79	6.37	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	60.07	27.92	5.28	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	68.39	29.47	6.35	0.28
corpus callosum, adult, pool1	10042-101F6	53.51	25.87	18.13	0.11
cruciate ligament, donor2	10295-104G7	50.25	46.20	12.16	0.81
diaphragm, fetal, donor1	10069-101I6	20.06	17.66	6.42	0.00
diencephalon, adult	10193-103E4	27.36	20.16	11.28	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	86.33	89.78	19.06	5.05
ductal cell carcinoma cell line:KLM-1	10438-106E6	12.82	7.95	1.28	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	23.11	9.87	7.70	0.24
ductus deferens, adult	10196-103E7	29.40	23.92	2.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	18.72	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.20	39.73	5.15	1.47
dura mater, adult, donor1	10041-101F5	51.86	33.78	11.31	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	15.55	19.10	7.77	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	24.65	15.48	5.59	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	17.88	6.78	4.93	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	17.56	6.05	5.15	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.98	5.25	3.70	0.31
embryonic pancreas cell line:2C6	10603-108E9	23.64	0.00	13.13	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	18.10	10.39	8.38	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	30.27	18.12	8.52	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	41.81	15.44	10.94	1.61
epidermoid carcinoma cell line:A431	10426-106D3	58.91	30.57	19.68	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	47.73	32.56	17.49	0.00
epididymis, adult	10197-103E8	35.37	16.74	5.65	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	19.52	10.82	4.08	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	14.55	3.15	4.72	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	18.08	7.21	4.72	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	24.41	10.63	9.84	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	18.60	6.95	6.27	0.34
esophagus, adult, pool1	10015-101C6	57.55	27.82	15.18	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	86.16	24.42	14.65	0.25
eye - muscle inferior rectus, donor1	10272-104E2	57.95	36.22	21.73	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	37.88	8.42	0.00
eye - muscle medial, donor2	10299-104H2	22.32	17.86	7.44	0.00
eye - muscle superior, donor2	10297-104G9	34.39	13.76	8.03	0.00
eye - vitreous humor, donor1	10268-104D7	18.95	20.40	8.74	1.46
eye, fetal, donor1	10054-101G9	27.97	23.14	11.69	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	23.47	14.23	4.62	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	30.86	18.52	8.07	0.00
frontal lobe, adult, pool1	10040-101F4	71.40	30.77	15.57	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	27.92	12.61	8.11	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	38.40	20.02	6.49	0.00
gall bladder, adult	10198-103E9	36.21	19.56	8.93	0.48
gamma delta positive T cells, donor1	11937-126A2	66.57	57.44	2.68	0.00
gamma delta positive T cells, donor2	11938-126A3	67.23	60.88	6.35	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.43	11.62	4.65	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	27.47	12.38	14.51	0.58
gastric cancer cell line:AZ521	10549-107H9	26.89	15.74	4.75	0.00
gastric cancer cell line:GSS	10560-108A2	21.97	10.98	4.58	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	48.89	54.14	20.79	2.06
giant cell carcinoma cell line:LU65	10487-107B1	10.67	4.59	5.28	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	40.03	26.31	5.32	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	36.42	14.22	8.98	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	31.35	11.19	3.80	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	33.42	10.53	6.32	0.14
glioblastoma cell line:T98G	10485-107A8	22.41	9.16	4.08	0.22
glioma cell line:GI-1	10413-106B8	23.72	15.82	4.98	0.29
globus pallidus - adult, donor10196	10175-103C4	50.29	18.95	24.78	2.92
globus pallidus, adult, donor10252	10161-103A8	60.54	29.29	30.27	0.24
globus pallidus, adult, donor10258	10367-105F7	67.09	9.58	8.22	0.00
globus pallidus, newborn, donor10223	10364-105F4	26.65	13.32	3.20	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	29.37	12.24	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	65.57	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	10.45	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	20.80	13.12	4.80	0.64
hIPS +CCl2, biol_rep1	14383-156B9	16.99	16.99	5.05	0.46
hIPS +CCl2, biol_rep2	14384-156C1	13.26	16.00	5.03	1.37
hIPS +CCl2, biol_rep3	14385-156C2	13.53	21.26	1.93	0.00
hIPS, biol_rep1	14380-156B6	8.62	17.25	1.44	0.00
hIPS, biol_rep2	14381-156B7	10.29	15.09	1.37	0.00
hIPS, biol_rep3	14382-156B8	39.72	15.45	12.14	0.00
hairy cell leukemia cell line:Mo	10712-109I1	47.99	17.82	9.19	0.29
heart - mitral valve, adult	10205-103F7	32.29	15.85	3.59	0.90
heart - pulmonic valve, adult	10206-103F8	26.93	16.47	3.40	0.78
heart - tricuspid valve, adult	10207-103F9	37.47	15.82	14.15	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	18.16	5.92	5.71	0.41
heart, adult, diseased, donor1	10051-101G6	14.48	7.66	2.98	0.43
heart, adult, pool1	10016-101C7	12.65	5.29	5.75	0.00
heart, fetal, pool1	10046-101G1	51.03	42.00	10.58	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	23.14	10.80	3.70	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	32.11	11.89	20.22	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.23	11.05	6.63	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	18.93	11.41	9.59	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	20.82	13.84	7.28	0.10
hepatoma cell line:Li-7	10484-107A7	22.13	10.12	7.12	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	28.34	16.98	10.65	0.10
hippocampus - adult, donor10196	10169-103B7	138.16	68.14	36.91	2.84
hippocampus, adult, donor10252	10153-102I9	76.33	40.41	40.21	0.61
hippocampus, adult, donor10258	10374-105G5	38.84	20.91	6.97	0.50
hippocampus, newborn, donor10223	10363-105F3	55.69	32.43	8.11	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	29.91	23.80	4.27	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	13.55	8.05	6.09	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	14.22	8.12	4.82	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	18.04	4.51	3.95	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	21.95	5.94	7.49	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	20.50	8.35	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	25.98	9.05	3.50	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	19.82	5.60	4.09	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	17.10	5.00	0.83	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	20.84	12.79	3.08	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	16.71	9.32	2.73	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	19.53	4.71	3.37	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	12.52	9.23	7.35	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	16.70	10.81	5.40	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.93	14.84	6.11	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	18.33	6.87	4.20	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	14.39	5.23	3.05	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.99	6.00	5.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	15.45	3.20	3.58	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	18.19	4.55	6.37	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	14.10	5.01	2.51	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	14.86	10.78	3.27	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.35	8.42	2.61	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.04	5.68	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	15.70	10.16	5.36	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.98	8.27	8.27	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	20.01	13.07	5.72	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	16.20	9.15	6.69	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	15.84	6.97	5.38	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	11.80	7.26	3.03	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	13.96	6.21	3.10	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	11.95	6.64	5.98	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	18.73	7.70	2.05	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	19.43	10.99	3.07	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	20.45	10.60	6.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.13	6.05	3.02	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	18.35	9.90	5.80	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.72	13.37	2.23	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	22.44	13.66	2.44	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	15.89	8.25	3.67	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	159.41	71.57	29.28	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	23.17	8.94	5.96	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	16.42	4.38	4.38	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.84	8.69	3.98	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	16.37	3.91	2.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	16.71	7.16	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	22.21	13.81	3.93	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.70	5.12	2.96	0.81
immature langerhans cells, donor1	11904-125F5	66.59	61.51	20.82	1.21
immature langerhans cells, donor2	11905-125F6	137.04	85.55	34.06	2.38
insula, adult, pool1	10039-101F3	72.02	32.27	13.34	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	31.54	16.26	10.40	1.30
kidney, adult, pool1	10017-101C8	41.55	23.13	7.31	0.60
kidney, fetal, pool1	10045-101F9	44.85	26.03	10.61	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	41.19	23.29	6.53	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.16	6.08	1.66	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	16.88	6.79	6.06	0.00
left atrium, adult, donor1	10079-102A7	14.17	5.45	4.36	1.09
left ventricle, adult, donor1	10078-102A6	9.10	9.61	3.03	0.00
leiomyoblastoma cell line:G-402	10721-110A1	21.62	7.66	4.92	0.27
leiomyoma cell line:10964C	10569-108B2	17.24	7.90	2.87	0.72
leiomyoma cell line:15242A	10570-108B3	15.22	4.35	0.54	0.54
leiomyoma cell line:15425	10571-108B4	27.92	9.96	4.13	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	12.70	6.35	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	44.96	20.91	8.36	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	84.41	57.38	18.65	0.47
liposarcoma cell line:KMLS-1	10782-110G8	30.30	17.34	8.59	0.31
liposarcoma cell line:SW 872	10726-110A6	11.57	7.43	4.14	0.24
liver, adult, pool1	10018-101C9	23.17	11.67	4.38	0.16
liver, fetal, pool1	10086-102B5	21.64	6.58	3.76	0.00
locus coeruleus - adult, donor10196	10182-103D2	43.75	20.12	16.04	0.87
locus coeruleus, adult, donor10252	10165-103B3	48.54	19.01	23.99	0.92
locus coeruleus, adult, donor10258	10375-105G6	26.80	7.34	7.62	0.28
locus coeruleus, newborn, donor10223	10362-105F2	67.30	31.13	7.99	1.26
lung adenocarcinoma cell line:A549	10499-107C4	18.54	14.25	6.50	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	47.57	17.92	4.14	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	30.19	18.32	7.91	0.13
lung, adult, pool1	10019-101D1	41.70	22.33	15.24	0.12
lung, fetal, donor1	10068-101I5	200.64	79.91	19.41	0.29
lung, right lower lobe, adult, donor1	10075-102A3	48.11	21.54	6.87	2.29
lymph node, adult, donor1	10077-102A5	28.88	22.25	9.47	2.37
lymphangiectasia cell line:DS-1	10727-110A7	27.18	10.74	7.89	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	49.20	66.71	19.17	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	44.17	60.31	13.59	0.00
mature adipocyte, donor1	12231-129F8	14.21	4.00	7.55	0.00
mature adipocyte, donor2	12232-129F9	15.77	10.58	9.96	0.00
mature adipocyte, donor3	12233-129G1	18.73	10.90	8.77	0.00
mature adipocyte, donor4	12234-129G2	29.22	14.21	6.84	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	39.31	26.69	12.87	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	76.71	31.58	24.82	7.90
medial frontal gyrus, adult, donor10252	10150-102I6	67.13	30.34	23.17	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	51.78	19.70	9.85	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	100.65	51.18	16.63	5.54
medial temporal gyrus - adult, donor10196	10183-103D3	83.53	34.09	24.81	7.76
medial temporal gyrus, adult, donor10252	10156-103A3	65.79	32.89	28.65	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	32.75	9.63	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	200.95	287.07	129.18	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	32.66	15.08	2.87	1.79
medulla oblongata - adult, donor10196	10174-103C3	60.35	25.96	23.36	1.30
medulla oblongata, adult, donor10252	10155-103A2	47.83	20.59	21.98	0.62
medulla oblongata, adult, pool1	10038-101F2	50.04	25.22	12.65	0.00
medulla oblongata, newborn, donor10223	10361-105F1	29.16	14.58	7.99	0.00
medulloblastoma cell line:D283 Med	10838-111E1	26.79	49.60	6.20	0.89
medulloblastoma cell line:ONS-76	10759-110E3	16.14	7.34	4.16	0.00
melanoma cell line:COLO 679	10514-107E1	12.94	9.49	0.86	0.00
melanoma cell line:G-361	10465-106H6	13.84	11.40	1.63	0.00
meningioma cell line:HKBMM	10691-109F7	15.02	11.76	3.98	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	30.84	21.15	14.10	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	13.48	9.85	3.11	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	31.45	16.72	7.98	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	24.00	12.54	5.82	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	28.57	12.84	4.56	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	26.41	14.05	6.04	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.41	11.55	7.51	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	21.52	11.80	2.78	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	19.39	11.84	8.58	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.93	10.24	5.06	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	25.07	13.26	5.17	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	26.87	18.23	6.62	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	33.43	13.94	13.09	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	26.02	16.80	5.60	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	29.20	13.70	5.40	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.58	9.08	3.14	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.38	11.43	5.10	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.13	7.91	2.88	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	22.76	10.24	4.86	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.50	8.21	5.24	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	48.67	22.66	12.17	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	20.02	14.35	5.53	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	22.41	11.73	5.95	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.03	11.04	2.21	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.46	7.73	5.44	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.63	8.00	4.21	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	18.72	12.79	5.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.81	11.51	5.88	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	22.25	14.40	6.28	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	20.03	15.10	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	23.77	12.94	3.77	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	25.72	12.18	3.05	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	15.72	11.40	5.50	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	20.39	10.66	2.32	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	25.09	13.56	6.63	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.19	12.05	3.79	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	20.19	12.98	3.61	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.07	17.60	10.27	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	26.52	9.06	2.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.06	14.33	3.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	24.06	16.32	3.87	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	10.94	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	16.56	12.02	3.57	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	13.09	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	22.39	5.33	1.60	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.90	13.90	2.45	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	16.33	8.55	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	6.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	5.96	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.01	11.27	2.96	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	6.09	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	10.13	3.17	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	19.31	16.90	3.10	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	4.30	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	11.98	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	10.33	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.41	13.04	0.81	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	12.71	17.48	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.02	7.07	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.78	13.71	3.43	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	4.01	5.35	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	9.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	5.14	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	7.57	12.39	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.41	5.94	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	4.49	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	5.72	2.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.82	3.22	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.07	1.21	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.12	8.24	2.47	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.94	5.16	0.99	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.14	7.79	2.27	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	7.13	7.13	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	19.34	9.28	12.38	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	25.75	10.16	12.99	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	29.19	8.57	7.88	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	12.82	12.82	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	42.02	19.01	10.69	1.85
mesothelioma cell line:Mero-25	10850-111F4	10.44	5.67	2.50	0.00
mesothelioma cell line:Mero-41	10851-111F5	28.85	8.80	3.91	0.98
mesothelioma cell line:Mero-48a	10852-111F6	8.64	5.98	1.33	0.00
mesothelioma cell line:Mero-82	10853-111F7	17.35	10.51	4.73	0.53
mesothelioma cell line:Mero-83	10854-111F8	15.32	16.17	2.72	0.17
mesothelioma cell line:Mero-84	10855-111F9	34.63	14.41	4.04	1.01
mesothelioma cell line:Mero-95	10856-111G1	23.60	8.70	2.48	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	22.53	6.96	1.66	0.33
mesothelioma cell line:NCI-H226	10846-111E9	26.06	17.19	4.52	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	70.38	21.01	6.83	0.34
mesothelioma cell line:NCI-H28	10845-111E8	30.28	15.27	4.58	0.51
mesothelioma cell line:No36	10857-111G2	23.16	10.11	7.83	0.65
mesothelioma cell line:ONE58	10858-111G3	20.05	10.30	2.71	0.54
migratory langerhans cells, donor1	11901-125F2	71.97	29.17	13.05	0.77
migratory langerhans cells, donor2	11902-125F3	56.05	16.36	8.79	0.24
migratory langerhans cells, donor3	11903-125F4	57.25	30.51	7.90	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	6.53	5.88	2.94	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.74	10.17	11.66	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	31.10	14.74	8.06	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	28.54	16.75	6.28	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	47.31	51.37	13.12	0.55
myeloma cell line:PCM6	10474-106I6	96.07	76.30	23.92	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	23.84	16.74	6.59	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	27.85	15.30	4.71	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	19.83	7.13	9.47	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.24	9.05	6.77	0.15
nasal epithelial cells, donor2	12227-129F4	42.50	26.50	14.35	0.55
neuroblastoma cell line:CHP-134	10508-107D4	14.49	27.61	3.68	0.00
neuroblastoma cell line:NB-1	10539-107G8	28.62	22.08	4.49	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	9.70	14.55	1.27	0.42
neuroblastoma cell line:NH-12	10555-107I6	14.72	39.13	5.78	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.25	53.85	8.07	2.61
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	36.59	54.96	21.54	1.43
neuroectodermal tumor cell line:TASK1	10774-110F9	11.27	11.27	2.82	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	9.54	6.36	6.36	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	26.62	11.45	2.93	0.27
neutrophil PMN, donor1	12133-128D9	29.75	44.62	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	92.96	26.56	0.00
neutrophil PMN, donor3	12141-128E8	56.82	18.94	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	159.31	76.95	23.00	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	27.22	10.41	6.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	17.63	10.58	6.41	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	24.17	8.41	6.04	1.58
nucleus accumbens, adult, pool1	10037-101F1	67.87	27.37	15.47	0.09
occipital cortex - adult, donor10196	10172-103C1	70.05	30.91	20.60	8.24
occipital cortex, adult, donor10252	10163-103B1	72.73	39.18	31.13	1.07
occipital cortex, newborn, donor10223	10355-105E4	35.30	19.65	5.82	0.73
occipital lobe, adult, donor1	10076-102A4	44.61	22.04	13.91	2.10
occipital lobe, fetal, donor1	10073-102A1	39.48	21.46	11.59	2.57
occipital pole, adult, pool1	10036-101E9	41.63	19.55	9.70	0.08
olfactory region, adult	10195-103E6	52.16	25.22	17.58	0.38
optic nerve, donor1	10277-104E7	20.01	18.01	14.01	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	46.82	23.01	14.35	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	21.16	13.33	7.28	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	41.82	33.02	8.47	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	21.72	22.18	8.55	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	33.81	18.81	4.41	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	43.91	5.61	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	30.75	18.66	5.94	0.42
ovary, adult, pool1	10020-101D2	25.33	14.85	9.00	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.23	6.60	6.05	0.00
pancreas, adult, donor1	10049-101G4	33.86	15.99	3.76	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.41	11.18	6.71	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	17.38	14.82	3.92	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	61.60	18.88	16.23	0.00
paracentral gyrus, adult, pool1	10035-101E8	59.03	25.72	12.36	0.18
parietal cortex, adult, donor10258	10373-105G4	44.04	23.49	7.34	0.00
parietal lobe - adult, donor10196	10171-103B9	58.31	31.04	21.63	0.94
parietal lobe, adult, donor10252	10157-103A4	72.40	38.77	27.08	2.00
parietal lobe, adult, pool1	10034-101E7	56.31	23.09	11.63	0.00
parietal lobe, fetal, donor1	10072-101I9	58.19	30.06	6.79	1.94
parietal lobe, newborn, donor10223	10356-105E5	49.72	22.06	8.22	0.00
parotid gland, adult	10199-103F1	37.62	36.38	4.32	1.85
penis, adult	10200-103F2	40.82	23.63	6.98	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	26.22	34.96	5.95	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	18.65	10.64	5.10	0.29
pineal gland - adult, donor10196	10179-103C8	47.09	29.67	10.97	0.00
pineal gland, adult, donor10252	10160-103A7	65.74	35.53	11.25	0.00
pineal gland, adult, donor10258	10377-105G8	32.61	13.17	1.25	1.88
pituitary gland - adult, donor10196	10180-103C9	49.58	27.32	6.07	4.05
pituitary gland, adult, donor10252	10162-103A9	52.64	31.79	18.76	0.00
pituitary gland, adult, donor10258	10378-105G9	19.58	13.62	2.55	0.85
placenta, adult, pool1	10021-101D3	38.59	20.86	8.17	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	37.74	27.81	13.51	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	28.48	9.65	6.07	0.16
pons, adult, pool1	10033-101E6	36.49	17.82	9.30	0.09
postcentral gyrus, adult, pool1	10032-101E5	53.09	23.89	12.99	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	8.37	27.19	12.55	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	44.06	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.33	13.98	4.95	0.58
prostate cancer cell line:PC-3	10439-106E7	25.59	10.16	7.08	0.00
prostate, adult, pool1	10022-101D4	41.72	19.77	7.44	0.27
putamen, adult, donor10196	10176-103C5	73.42	33.05	38.95	0.71
putamen, adult, donor10252	10152-102I8	39.21	15.69	11.76	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	18.58	12.02	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	42.28	19.57	8.21	0.24
putamen, newborn, donor10223	10365-105F5	77.96	41.23	13.49	3.00
rectal cancer cell line:TT1TKB	10469-106I1	41.02	20.07	18.62	0.29
rectum, fetal, donor1	10067-101I4	41.73	23.65	13.91	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	36.46	16.96	7.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	18.23	8.28	12.43	0.41
retina, adult, pool1	10030-101E3	63.72	36.18	18.69	0.20
retinoblastoma cell line:Y79	10475-106I7	34.29	38.19	9.35	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	11.19	9.22	2.83	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	11.81	9.00	3.94	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	33.35	10.61	3.79	0.00
salivary acinar cells, donor1	11771-123I7	22.17	29.94	5.83	0.97
salivary acinar cells, donor2	11772-123I8	25.61	39.24	6.06	0.28
salivary acinar cells, donor3	11773-123I9	40.39	33.10	15.89	0.00
salivary gland, adult, pool1	10093-102C3	73.21	50.33	12.01	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	37.52	23.10	6.74	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	38.79	23.39	8.11	0.24
seminal vesicle, adult	10201-103F3	31.22	17.99	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	29.88	12.88	6.56	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.13	16.36	3.52	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	44.16	13.05	6.02	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	24.98	17.33	7.25	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	18.24	13.37	5.97	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	45.80	27.10	7.48	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	22.70	13.48	7.80	0.00
skeletal muscle, adult, pool1	10023-101D5	18.11	14.51	9.48	0.12
skeletal muscle, fetal, donor1	10066-101I3	15.08	11.06	4.02	0.00
skin, adult, donor1	10074-102A2	54.28	33.93	13.57	0.00
skin, fetal, donor1	10065-101I2	75.75	41.03	10.10	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	23.35	15.34	5.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	29.00	22.38	9.14	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	26.02	10.22	14.65	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	65.77	83.90	23.57	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	11.58	13.19	4.66	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	20.27	23.75	3.05	0.00
small intestine, adult, pool1	10024-101D6	60.08	38.34	15.17	0.36
small intestine, fetal, donor1	10064-101I1	29.48	28.50	13.76	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	51.80	30.77	9.75	2.56
smooth muscle, adult, pool1	10048-101G3	33.60	17.06	6.20	0.52
somatostatinoma cell line:QGP-1	10781-110G7	38.33	16.35	9.65	0.00
spinal cord - adult, donor10196	10181-103D1	61.02	29.82	23.86	2.52
spinal cord, adult, donor10252	10159-103A6	72.94	37.06	25.63	0.00
spinal cord, adult, donor10258	10369-105F9	51.19	38.74	15.22	0.69
spinal cord, fetal, donor1	10056-101H2	37.20	32.93	15.86	1.83
spinal cord, newborn, donor10223	10359-105E8	61.08	25.26	11.48	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	38.09	12.99	4.48	0.30
spleen, adult, pool1	10025-101D7	47.69	29.30	8.37	0.22
spleen, fetal, pool1	10044-101F8	57.21	37.11	10.33	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	46.06	19.36	8.49	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	18.99	13.29	6.46	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	27.61	15.03	7.69	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	25.80	9.38	1.95	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	20.71	16.43	7.88	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	27.11	13.98	4.66	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	32.58	19.88	5.50	0.00
stomach, fetal, donor1	10062-101H8	50.19	18.16	13.88	1.07
submaxillary gland, adult	10202-103F4	43.87	36.46	9.68	1.71
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	41.96	24.30	16.41	0.21
substantia nigra, adult, donor10258	10371-105G2	35.17	25.86	8.28	0.00
substantia nigra, newborn, donor10223	10358-105E7	38.86	12.72	3.53	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	35.54	23.61	8.94	0.23
temporal lobe, adult, pool1	10031-101E4	49.34	20.94	10.34	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	37.04	34.90	16.38	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	38.24	30.33	2.20	1.32
tenocyte, donor1	11763-123H8	26.53	10.82	6.98	0.35
tenocyte, donor2	11765-123I1	22.89	16.79	3.82	0.38
tenocyte, donor3	11768-123I4	23.72	12.60	4.08	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	34.50	14.45	10.20	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	30.21	25.43	7.40	0.46
teratocarcinoma cell line:PA-1	10807-111A6	19.37	13.48	7.90	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	27.55	15.74	8.25	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	20.42	13.24	6.81	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	71.65	38.61	31.74	0.98
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	21.50	14.98	5.86	1.30
testis, adult, pool1	10026-101D8	36.40	22.44	10.52	0.21
testis, adult, pool2	10096-102C6	28.42	24.81	6.32	0.45
thalamus - adult, donor10196	10168-103B6	71.76	26.50	29.81	2.21
thalamus, adult, donor10252	10154-103A1	50.32	22.04	23.13	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	36.95	24.63	10.78	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	20.26	9.06	4.45	0.33
thalamus, newborn, donor10223	10366-105F6	59.83	24.74	9.78	1.15
throat, adult	10209-103G2	44.69	31.96	7.74	1.50
throat, fetal, donor1	10061-101H7	37.17	27.73	11.58	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	23.05	11.73	3.58	0.60
thymus, adult, pool1	10027-101D9	61.04	84.11	15.61	0.50
thymus, fetal, pool1	10043-101F7	91.02	96.32	26.08	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	54.38	14.23	11.04	1.99
thyroid carcinoma cell line:TCO-1	10783-110G9	29.75	24.45	8.80	0.70
thyroid, adult, pool1	10028-101E1	39.00	17.92	8.77	0.37
thyroid, fetal, donor1	10060-101H6	31.64	18.72	6.06	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	92.39	55.43	21.56	0.00
tongue, adult	10203-103F5	50.00	25.82	7.68	1.16
tongue, fetal, donor1	10059-101H5	30.74	29.16	11.82	0.39
tonsil, adult, pool1	10047-101G2	95.67	58.90	17.53	0.30
trachea, adult, pool1	10029-101E2	52.27	29.28	11.94	0.16
trachea, fetal, donor1	10058-101H4	40.78	28.47	12.31	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	30.47	6.73	4.96	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	30.29	13.17	7.90	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	38.86	30.71	5.80	0.31
tridermal teratoma cell line:HGRT	10694-109G1	15.22	15.22	9.51	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	24.13	13.80	3.98	0.42
umbilical cord, fetal, donor1	10057-101H3	27.12	22.95	8.35	2.09
uterus, adult, pool1	10100-102D1	61.43	37.71	7.68	0.17
uterus, fetal, donor1	10055-101H1	33.79	26.11	11.26	0.51
vagina, adult	10204-103F6	40.06	12.28	9.69	0.00
vein, adult	10191-103E2	39.46	28.71	7.67	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	33.91	22.43	11.48	0.53